| Product Code: ETC7647440 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Israel continued to import cardiotonic agents mainly from Switzerland, UK, Belgium, USA, and Germany. The market remained highly diversified with a low concentration level, indicated by the low Herfindahl-Hirschman Index (HHI). Despite a slight decline in the compound annual growth rate (CAGR) from 2020-2024 at -2.14%, the market saw a marginal improvement in the growth rate from 2023-2024 at -0.41%. This suggests a stable market outlook with steady import patterns from key exporting countries.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Cardiotonic Agents Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Cardiotonic Agents Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Cardiotonic Agents Market - Industry Life Cycle |
3.4 Israel Cardiotonic Agents Market - Porter's Five Forces |
3.5 Israel Cardiotonic Agents Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Israel Cardiotonic Agents Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Israel Cardiotonic Agents Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Israel Cardiotonic Agents Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.9 Israel Cardiotonic Agents Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Cardiotonic Agents Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in Israel |
4.2.2 Growing geriatric population in Israel |
4.2.3 Technological advancements in cardiotonic agents |
4.2.4 Rising awareness about cardiovascular health |
4.2.5 Favorable government initiatives and healthcare policies |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for cardiotonic agents |
4.3.2 High costs associated with cardiotonic agents |
4.3.3 Potential side effects and safety concerns of cardiotonic agents |
4.3.4 Competition from alternative therapies |
4.3.5 Limited access to advanced cardiotonic agents in certain regions of Israel |
5 Israel Cardiotonic Agents Market Trends |
6 Israel Cardiotonic Agents Market, By Types |
6.1 Israel Cardiotonic Agents Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Cardiotonic Agents Market Revenues & Volume, By Drug Type, 2021- 2031F |
6.1.3 Israel Cardiotonic Agents Market Revenues & Volume, By Digitalis Glycosides, 2021- 2031F |
6.1.4 Israel Cardiotonic Agents Market Revenues & Volume, By Phosphodiesterase Inhibitors, 2021- 2031F |
6.1.5 Israel Cardiotonic Agents Market Revenues & Volume, By Cardioprotectants, 2021- 2031F |
6.1.6 Israel Cardiotonic Agents Market Revenues & Volume, By Sympathomimetic Agents, 2021- 2031F |
6.1.7 Israel Cardiotonic Agents Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Israel Cardiotonic Agents Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Israel Cardiotonic Agents Market Revenues & Volume, By Cardiac Surgical Procedures, 2021- 2031F |
6.2.3 Israel Cardiotonic Agents Market Revenues & Volume, By Atrial Fibrillation, 2021- 2031F |
6.2.4 Israel Cardiotonic Agents Market Revenues & Volume, By Heart Failure, 2021- 2031F |
6.2.5 Israel Cardiotonic Agents Market Revenues & Volume, By Pulmonary Hypertension, 2021- 2031F |
6.2.6 Israel Cardiotonic Agents Market Revenues & Volume, By Others (Atrial Flutter, Cardiogenic Shock, etc.), 2021- 2031F |
6.3 Israel Cardiotonic Agents Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Israel Cardiotonic Agents Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Israel Cardiotonic Agents Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4 Israel Cardiotonic Agents Market, By Dosage Form |
6.4.1 Overview and Analysis |
6.4.2 Israel Cardiotonic Agents Market Revenues & Volume, By Tablet, 2021- 2031F |
6.4.3 Israel Cardiotonic Agents Market Revenues & Volume, By Solution, 2021- 2031F |
6.4.4 Israel Cardiotonic Agents Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Israel Cardiotonic Agents Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Israel Cardiotonic Agents Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.5.3 Israel Cardiotonic Agents Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.5.4 Israel Cardiotonic Agents Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
7 Israel Cardiotonic Agents Market Import-Export Trade Statistics |
7.1 Israel Cardiotonic Agents Market Export to Major Countries |
7.2 Israel Cardiotonic Agents Market Imports from Major Countries |
8 Israel Cardiotonic Agents Market Key Performance Indicators |
8.1 Patient adherence rate to cardiotonic agent treatment |
8.2 Average time to market for new cardiotonic agents |
8.3 Rate of adoption of novel cardiotonic agents |
8.4 Number of clinical trials for cardiotonic agents conducted in Israel |
8.5 Percentage of cardiologists recommending specific cardiotonic agents |
9 Israel Cardiotonic Agents Market - Opportunity Assessment |
9.1 Israel Cardiotonic Agents Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Israel Cardiotonic Agents Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Israel Cardiotonic Agents Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Israel Cardiotonic Agents Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.5 Israel Cardiotonic Agents Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Cardiotonic Agents Market - Competitive Landscape |
10.1 Israel Cardiotonic Agents Market Revenue Share, By Companies, 2024 |
10.2 Israel Cardiotonic Agents Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here